These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 35803214)

  • 61. LEO1 is regulated by PRL-3 and mediates its oncogenic properties in acute myelogenous leukemia.
    Chong PS; Zhou J; Cheong LL; Liu SC; Qian J; Guo T; Sze SK; Zeng Q; Chng WJ
    Cancer Res; 2014 Jun; 74(11):3043-53. PubMed ID: 24686170
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Expression of aberrantly spliced oncogenic Ikaros isoforms coupled with clonal IKZF1 deletions and chimeric oncogenes in acute lymphoblastic leukemia.
    Vshyukova V; Valochnik A; Meleshko A
    Blood Cells Mol Dis; 2018 Jul; 71():29-38. PubMed ID: 29496375
    [No Abstract]   [Full Text] [Related]  

  • 63. Oncogenic Effect of the Novel Fusion Gene
    Yoon D; Bae K; Kim JH; Choi YK; Yoon KA
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31083279
    [TBL] [Abstract][Full Text] [Related]  

  • 64. KRAB-ZFP Transcriptional Regulators Acting as Oncogenes and Tumor Suppressors: An Overview.
    Sobocińska J; Molenda S; Machnik M; Oleksiewicz U
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672287
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Identification of RSPO2 Fusion Mutations and Target Therapy Using a Porcupine Inhibitor.
    Li C; Cao J; Zhang N; Tu M; Xu F; Wei S; Chen X; Xu Y
    Sci Rep; 2018 Sep; 8(1):14244. PubMed ID: 30250044
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Coupled alteration of transcription and splicing by a single oncogene: boosting the effect on cyclin D1 activity.
    Sanchez G; Delattre O; Auboeuf D; Dutertre M
    Cell Cycle; 2008 Aug; 7(15):2299-305. PubMed ID: 18677114
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Interplay among Drosophila transcription factors Ets21c, Fos and Ftz-F1 drives JNK-mediated tumor malignancy.
    Külshammer E; Mundorf J; Kilinc M; Frommolt P; Wagle P; Uhlirova M
    Dis Model Mech; 2015 Oct; 8(10):1279-93. PubMed ID: 26398940
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Oncogenic cancer/testis antigens are a hallmarker of cancer and a sensible target for cancer immunotherapy.
    Yang P; Meng M; Zhou Q
    Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188558. PubMed ID: 33933558
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Detecting and targetting oncogenic fusion proteins in the genomic era.
    Davare MA; Tognon CE
    Biol Cell; 2015 May; 107(5):111-29. PubMed ID: 25631473
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Fusion oncogenes.
    Aman P
    Semin Cancer Biol; 2005 Jun; 15(3):159-61. PubMed ID: 15826830
    [No Abstract]   [Full Text] [Related]  

  • 71. Molecular mechanisms underlying oncogenic RET fusion in lung adenocarcinoma.
    Mizukami T; Shiraishi K; Shimada Y; Ogiwara H; Tsuta K; Ichikawa H; Sakamoto H; Kato M; Shibata T; Nakano T; Kohno T
    J Thorac Oncol; 2014 May; 9(5):622-30. PubMed ID: 24722152
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Recent progress of molecular diagnosis in pediatric malignancies].
    Hayashi Y
    Gan To Kagaku Ryoho; 2003 Sep; 30(9):1211-24. PubMed ID: 14518398
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Oncogenic drivers in daily practice improve overall survival in patients with lung adenocarcinoma].
    Fournier C; Greillier L; Fina F; Secq V; Nanni-Metellus I; Loundou A; Garcia S; Ouafik L; Tomasini P; Barlesi F
    Rev Mal Respir; 2016 Nov; 33(9):751-756. PubMed ID: 27017063
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Oncogenic seRNA functional activation: a novel mechanism of tumorigenesis.
    Tan Y; Li Y; Tang F
    Mol Cancer; 2020 Apr; 19(1):74. PubMed ID: 32278350
    [TBL] [Abstract][Full Text] [Related]  

  • 75. MYC Analysis in Cancer and Evolution.
    Hartl M; Bister K
    Methods Mol Biol; 2021; 2318():87-117. PubMed ID: 34019288
    [TBL] [Abstract][Full Text] [Related]  

  • 76. On the right TRK: from oncogene discovery to cancer therapeutics.
    Barbacid M
    Ann Oncol; 2019 Nov; 30 Suppl 8(Suppl 8):viii3-viii4. PubMed ID: 32223936
    [No Abstract]   [Full Text] [Related]  

  • 77. Both Pbx1 and E2A-Pbx1 bind the DNA motif ATCAATCAA cooperatively with the products of multiple murine Hox genes, some of which are themselves oncogenes.
    Lu Q; Knoepfler PS; Scheele J; Wright DD; Kamps MP
    Mol Cell Biol; 1995 Jul; 15(7):3786-95. PubMed ID: 7791786
    [TBL] [Abstract][Full Text] [Related]  

  • 78. E2A-Pbx1, the t(1;19) translocation protein of human pre-B-cell acute lymphocytic leukemia, causes acute myeloid leukemia in mice.
    Kamps MP; Baltimore D
    Mol Cell Biol; 1993 Jan; 13(1):351-7. PubMed ID: 8093327
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Small interfering RNAs expressed from a Pol III promoter suppress the EWS/Fli-1 transcript in an Ewing sarcoma cell line.
    Dohjima T; Lee NS; Li H; Ohno T; Rossi JJ
    Mol Ther; 2003 Jun; 7(6):811-6. PubMed ID: 12788655
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Profiling oncogenic extra-chromosomal DNA in cancer.
    Nat Genet; 2022 Nov; 54(11):1591-1592. PubMed ID: 36319855
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.